YTHDF2 and ovarian carcinoma: By employing a LC-MS/MS assay that allows quantification of m6A level in cells, we showed that ablation of YTHDF2 significantly increases m6A abundance in the ovarian cancer cell lines, OVCAR8 and HEY (Fig. 6a), which is in accordance with a previous study performed in HeLa cells [24].